[1]
Rodriguez-Rodriguez L, Lamas JR, Varade J, et al. Combined influence of genetic and environmental factors in age of rheumatoid arthritis onset. Rheumatol Int 2012; 32: 3097-102.
[2]
Mellado M, Martínez-Muñoz L, Cascio G, Lucas P, Pablos JL, Rodríguez-Frade JM. T cell Migration in Rheumatoid Arthritis. Front Immunol 2015; 6: 384.
[3]
Postal M, Appenzeller S. The role of Tumor Necrosis Factor-alpha (TNF-α) in the pathogenesis of systemic lupus erythematosus. Cytokine 2011; 56: 537-43.
[4]
Feldmann M, Maini RN. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? Annu Rev Immunol 2001; 19: 163-96.
[5]
Alonso-Ruiz A, Pijoan JI, Ansuategui E, Urkaregi A, Calabozo M, Quintana A. Tumor necrosis factor alpha drugs in rheumatoid arthritis: Systematic review and metaanalysis of efficacy and safety. BMC Musculoskelet Disord 2008; 9: 52.
[6]
Rubbert-Roth A. Assessing the safety of biologic agents in patients with rheumatoid arthritis. Rheumatology 2012; 5: v38-47.
[7]
Sharma A, Sahu S, Kumari P, Gopi SR, Malhotra R, Biswas S. Genome-wide identification and functional annotation of miRNAs in anti-inflammatory plant and their cross-kingdom regulation in Homo sapiens. J Biomol Struct Dyn 2016; 29: 1-12.
[8]
Christopher AF, Kaur RP, Kaur G, Kaur A, Gupta V, Bansal P. MicroRNA therapeutics: Discovering novel targets and developing specific therapy. Perspect Clin Res 2016; 7: 68-74.
[9]
Gopi SR, Sharma A, Biswas S. Identification of the potential inhibitor for C. pneumonia derived HSP60 from medicinally important plants; A therapeutic approach for reducing inflammation in CAD. Innov Approach Stem Cell Res Cancer Biology Appl Biotechnol 2014; 1: 119.
[10]
Mann S, Sharma A, Biswas S, Gupta RK. Identification and molecular docking analysis of active ingredients with medicinal properties from edible Baccaurea sapida. Bioinformation 2015; 11: 437-43.
[11]
Goyal KA, Mishra T, Sen A. Antioxidant profiling of Latkan (Baccaurea ramiflora Lour.) wine. Indian J Biotechnol 2013; 12: 137-9.
[12]
Li Y, Yao J, Han C, et al. Quercetin, Inflammation and Immunity. Nutrients 2016; 8: 167.
[13]
Chen S, Jiang H, Wu X, Fang J. Therapeutic effects of quercetin on inflammation, obesity, and type 2 diabetes. Mediators Inflamm 2016; 2016: 9340637.
[14]
Huang J, Zhu M, Tao Y, et al. Therapeutic properties of quercetin on monosodium urate crystal-induced inflammation in rat. J Pharm Pharmacol 2012; 64: 1119-27.
[15]
Maunz A, Gütlein M, Rautenberg M, Vorgrimmler D, Gebele D, Helma C. Lazar: A modular predictive toxicology framework. Front Pharmacol 2013; 4: 38.
[16]
Paramashivam SK, Elayaperumal K, Natarajan BB, Ramamoorthy MD, Balasubramanian S, Dhiraviam KN. In-silico pharmacokinetic and molecular docking studies of small molecules derived from Indigofera aspalathoides Vahl targeting receptor tyrosine kinases. Bioinformation 2015; 11: 73-84.
[17]
Morris GM, Huey R, Lindstrom W, et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem 2009; 30: 2785-91.
[18]
Sharma S, Ghosh S, Singh LK, et al. Identification of autoantibodies against transthyretin for the screening and diagnosis of rheumatoid arthritis. PLoS One 2014; 9: e93905.
[19]
Kumar P, Banik S. Pharmacotherapy options in rheumatoid arthritis. Clin Med Insights Arthritis Musculoskelet Disord 2013; 6: 35-43.
[20]
Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet 2010; 376: 1094-108.
[21]
Negrei C, Bojinca V, Balanescu A, et al. Management of rheumatoid arthritis: Impact and risks of various therapeutic approaches. Exp Ther Med 2016; 11: 1177-83.
[22]
Shakiba K, Falcone T. Tumour necrosis factor-alpha blockers: potential limitations in the management of advanced endometriosis? A case report. Hum Reprod 2006; 21: 2417-20.
[23]
Gómez-Reino J. Biologic monotherapy as initial treatment in patients with early rheumatoid arthritis. Rheumatology 2012; 5: v31-7.
[24]
Leombruno JP, Einarson TR, Keystone EC. The safety of anti-tumour necrosis factor treatments in rheumatoid arthritis: meta and exposure-adjusted pooled analyses of serious adverse events. Ann Rheum Dis 2009; 68: 1136-45.
